WallStreetZenWallStreetZen

NASDAQ: ROIV
Roivant Sciences Ltd Earnings & Revenue

ROIV past revenue growth

How has ROIV's revenue growth performed historically?
Company
185.76%
Industry
165.61%
Market
17.84%
ROIV's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ROIV's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ROIV's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ROIV earnings and revenue history

Current Revenue
$123.2M
Current Earnings
$4.5B
Current Profit Margin
3,624.1%

ROIV Return on Equity

Current Company
196.2%
Current Industry
-63.6%
Current Market
188%
ROIV's Return on Equity (196.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ROIV announces earnings.

ROIV Return on Assets

Current Company
128.5%
Current Industry
3%
ROIV is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ROIV Return on Capital Employed

Current Company
64.37%
Current Industry
19.6%

ROIV vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ROIV$123.24M$4.58B$4.47B+41.90%N/A
ASND$286.79M-$442.12M-$517.68M+89.39%N/A
VKTX$0.00-$85.60M-$85.90MN/AN/A
CERE$0.00-$416.15M-$432.84MN/AN/A
JAZZ$3.83B$1.22B$414.83M+15.19%-2.54%

Roivant Sciences Earnings & Revenue FAQ

What were ROIV's earnings last quarter?

On Invalid Date, Roivant Sciences (NASDAQ: ROIV) reported Q4 2023 earnings per share (EPS) of $6.37, up 1,400% year over year. Total Roivant Sciences earnings for the quarter were $5.10 billion. In the same quarter last year, Roivant Sciences's earnings per share (EPS) was -$0.49.

If you're new to stock investing, here's how to buy Roivant Sciences stock.

What was ROIV's earnings growth in the past year?

As of Q1 2024, Roivant Sciences's earnings has grown year over year. Roivant Sciences's earnings in the past year totalled $4.47 billion.

What was ROIV's revenue last quarter?

On Invalid Date, Roivant Sciences (NASDAQ: ROIV) reported Q4 2023 revenue of $37.14 million up 117.8% year over year. In the same quarter last year, Roivant Sciences's revenue was $17.05 million.

What was ROIV's revenue growth in the past year?

As of Q1 2024, Roivant Sciences's revenue has grown 185.76% year over year. This is 20.15 percentage points higher than the US Biotechnology industry revenue growth rate of 165.61%. Roivant Sciences's revenue in the past year totalled $123.24 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.